A spectacular effect of tocilizumab in Takayasu arteritis

Background: Anti-interleukin-6 receptors (anti-IL-6R) have been a promising new therapeutic alternative in the treatment of Takayasu arteritis. Case description: We report the case of a 34-year-old patient with Takayasu arteritis diagnosed in 2017. While she was on corticosteroid and methotrexate, t...

Full description

Bibliographic Details
Main Authors: Fatma Saïd, Ines Naceur, Tayssir Ben Achour, Mayssam Jridi, Monia Smiti
Format: Article
Language:English
Published: SMC MEDIA SRL 2024-11-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/4868